About Candid Therapeutics
Candid Therapeutics is a private company based in San Diego, California, incorporated in 2024 in Delaware. It has reported $206,203,454 raised in one offering on Form D since September 2024. Its chief executive is Kenneth Song, M.D..
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2024 | Sep 13, 2024 | $206,203,454fully sold | 33 | $6.2M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Candid Therapeutics's Form D filed Sep 13, 2024.
JD
Jeffrey Tong, Ph.D.
Director
AK
Arvind Kush
Executive officer
TD
Timothy Lu, M.D.
Executive officer
KD
Kenneth Song, M.D.
President and CEO, director
AD
Aaron Royston, M.D.
Director
BD
Bernie Huyghe, Ph.D.
Executive officer
MD
Michael Rome, M.D.
Director